Submit Search
Upload
Giab sv genotyping
•
Download as PPTX, PDF
•
1 like
•
197 views
GenomeInABottle
Follow
An assessment of computational genotyping of SVs for clinical diagnosis
Read less
Read more
Health & Medicine
Report
Share
Report
Share
1 of 14
Download now
Recommended
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
GenomeInABottle
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016
GenomeInABottle
Giab v0.6 genoox sv benchmarking
Giab v0.6 genoox sv benchmarking
Giab v0.6 genoox sv benchmarking
GenomeInABottle
Genome in a Bottle- reference materials to benchmark challenging variants and regions of the human genome
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...
GenomeInABottle
How giab fits in the rest of the world seqc2 tumor normal
How giab fits in the rest of the world seqc2 tumor normal
How giab fits in the rest of the world seqc2 tumor normal
GenomeInABottle
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GenomeInABottle
New methods diploid assembly with graphs
New methods diploid assembly with graphs
New methods diploid assembly with graphs
GenomeInABottle
Jason Chin MHC diploid assembly
Jason Chin MHC diploid assembly
Jason Chin MHC diploid assembly
GenomeInABottle
Recommended
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
Genome in a bottle for amp GeT-RM 181030
GenomeInABottle
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016
Genome in a bottle for ashg grc giab workshop 181016
GenomeInABottle
Giab v0.6 genoox sv benchmarking
Giab v0.6 genoox sv benchmarking
Giab v0.6 genoox sv benchmarking
GenomeInABottle
Genome in a Bottle- reference materials to benchmark challenging variants and regions of the human genome
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...
GenomeInABottle
How giab fits in the rest of the world seqc2 tumor normal
How giab fits in the rest of the world seqc2 tumor normal
How giab fits in the rest of the world seqc2 tumor normal
GenomeInABottle
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GIAB Benchmarks for SVs and Repeats for stanford genetics sv 200511
GenomeInABottle
New methods diploid assembly with graphs
New methods diploid assembly with graphs
New methods diploid assembly with graphs
GenomeInABottle
Jason Chin MHC diploid assembly
Jason Chin MHC diploid assembly
Jason Chin MHC diploid assembly
GenomeInABottle
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
GenomeInABottle
Since its inception, next-generation sequencing has found utility in a diverse set of industries, from biomarker discovery in pharma to ancestral identification in archeology. Across the board, NGS has the advantage of allowing us to answer questions that require a lot of data. Next-generation sequencing provides orders of magnitude more data than traditional Sanger sequencing as hundreds of “lanes” analyzed in parallel vs. hundreds of millions of “clusters” which allows for many samples to be multiplexed on a single-run. By starting with different genetic material and following specific experimental workflows, NGS can be applied to many applications. Here we focus on DNA resequencing applications, which implies the data generated will be compared to an existing reference sequence (such as the human genome). Specifically, we’ll focus on how we can analyze patient-derived material to identify onco-relevant mutations including single-nucleotide variants, insertions-deletions, copy number variants and translocations. We’ll also focus on how known reference standards have been shown to be vital in ensuring data generated from NGS assays is accurate and reproducible.
Molecular QC: Using Reference Standards in NGS Pipelines
Molecular QC: Using Reference Standards in NGS Pipelines
Candy Smellie
DNA sequence analysis and genotyping of biological samples using innovative instrumentation, such as next-generation sequencing (NGS) platforms, is often limited by the small amount of sample available. The REPLI-g Single Cell Kit is specially designed to uniformly amplify genomic DNA from single cells (1 to <1000 bacterial or tumor cells) or purified genomic DNA with complete genome coverage. Additional protocols are also available for use with fresh or dried blood or fresh or frozen tissue. Dedicated buffers and reagents undergo a unique, controlled decontamination procedure to avoid amplification of contaminating DNA, ensuring highly reliable results every time. Accurate amplification of genomes with negligible sequence bias and no genomic drop-outs is achieved with innovative Multiple Displacement Amplification (MDA) technology. In contrast to PCR-based WGA technologies, high fidelity rates are increased up to 1000-fold, avoiding costly false positive or negative results.
Whole Genome Amplification from Single Cell
Whole Genome Amplification from Single Cell
QIAGEN
Genome in a Bottle: Towards new benchmarks for the “dark matter” of the human genome
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
GenomeInABottle
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GenomeInABottle
GIAB for AMP GeT-RM Forum - How well can you detect difficult variants? Benchmarking with Genome in a Bottle
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM Forum
GenomeInABottle
Tools for Using NIST Reference Materials
Tools for Using NIST Reference Materials
Tools for Using NIST Reference Materials
GenomeInABottle
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
GenomeInABottle
What is the impact of assay failure in your laboratory and how do you monitor for it? The most heavily degraded samples are not suitable for standard exome coverage: sometimes it’s not even a matter of getting bad sequencing, you might get nothing at all! FFPE artifacts increase with storage time Artifacts go against the statistical power of your variant calling analysis Molecular reference standards help filter out bad mappings and spurious variants Bioinformatics pipelines allow adding Molecular Reference Standards in your joint variant calling pipeline Genome In A Bottle Reference Standards are invaluable for validating variant calling analysis NIST and its collaborators shared datasets created with most NGS technologies Horizon Diagnostics shared annotated, merged variant calls from NIST for the Ashkenazim Trio ~35K variants are predicted having high or moderate impact within the Trio GM24385 (Ashkenazim Son) includes 352 small variants with high/moderate impact which are absent in Father and Mother Routinely monitor the performance of your workflows and assays with independent external controls
Molecular QC: Interpreting your Bioinformatics Pipeline
Molecular QC: Interpreting your Bioinformatics Pipeline
Candy Smellie
GIAB Technical Germline Benchmark roadmap discussion
GIAB Technical Germline Benchmark roadmap discussion
GIAB Technical Germline Benchmark roadmap discussion
GenomeInABottle
Aug2013 illumina platinum genomes
Aug2013 illumina platinum genomes
GenomeInABottle
Next generation sequencing has revolutionized clinical testing but has also created novel challenges. This presentation will give an overview of state of the art clinical NGS and discuss validation, clinical implementation as well as the migration from gene panels to exome sequencing for inherited disorders with clinical and genetic heterogeneity. In addition, important shortcomings such as difficulties with regions of high sequence homology will be discussed.
NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1
QIAGEN
This slidedeck details two comprehensive informatics solutions — the Biomedical Genomics Workbench and Ingenuity Knowledge Base Variant Analysis platforms. We show the intuitive user interface of CLC Cancer Research Workbench and demonstrate how the rich biological content from Ingenuity Knowledge Base helps you rapidly identify critical variants in your samples.
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
QIAGEN
Aug2013 NIST highly confident genotype calls for NA12878
Aug2013 NIST highly confident genotype calls for NA12878
GenomeInABottle
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2A, SMAD4, TP53 and many others. We have shown that KRAS mutation can be detected in cell-free, circulating tumor DNA (ctDNA) isolated from the plasma in a subset of patients and is associated with poor prognosis. The ability to simultaneously detect multiple pancreatic cancer-specific mutations in ctDNA would open a new avenue for detection of clinically-relevant mutations. In this study, we performed ultra-deep sequencing of ctDNA from advanced pancreatic cancer patients prior to treatment with Gemcitabine and Erlotinib following target enrichment. Somatic, non-synonymous variants were identified in 29 different genes at allele frequencies typically less than 0.5%. Updated results of ultra-deep NGS analysis will be presented.
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
QIAGEN
GIAB ASHG 2019 Structural Variant poster
GIAB ASHG 2019 Structural Variant poster
GIAB ASHG 2019 Structural Variant poster
GenomeInABottle
GIAB and long reads for bio it world 190417
GIAB and long reads for bio it world 190417
GIAB and long reads for bio it world 190417
GenomeInABottle
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GenomeInABottle
Identification and monitoring of cancer mutations from cell free DNA-Seq data is a key application in liquid biopsy. In this part of the webinar we will show how mutations can be best identified from this type of data and how they can be interpreted. Furthermore, potential challenges when analyzing this type of data will be discussed together with relevant strategies.
Analysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNA
QIAGEN
ABRF update
Aug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plans
GenomeInABottle
Presentation by Fritz Sedlazeck at GRC/GIAB ASHG 2017 workshop "Getting the most from the reference assembly and reference materials" on characterizing human structural variation.
Ashg sedlazeck grc_share
Ashg sedlazeck grc_share
Genome Reference Consortium
Tute Genomics is cloud-based software that can rapidly analyze entire human genomes. The cost of whole genome sequencing is dropping rapidly and we are in the middle of a genomic revolution. Tute is opening a new door for personalized medicine by helping researchers & healthcare organizations analyze human genomes.
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Reid Robison
More Related Content
What's hot
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
GenomeInABottle
Since its inception, next-generation sequencing has found utility in a diverse set of industries, from biomarker discovery in pharma to ancestral identification in archeology. Across the board, NGS has the advantage of allowing us to answer questions that require a lot of data. Next-generation sequencing provides orders of magnitude more data than traditional Sanger sequencing as hundreds of “lanes” analyzed in parallel vs. hundreds of millions of “clusters” which allows for many samples to be multiplexed on a single-run. By starting with different genetic material and following specific experimental workflows, NGS can be applied to many applications. Here we focus on DNA resequencing applications, which implies the data generated will be compared to an existing reference sequence (such as the human genome). Specifically, we’ll focus on how we can analyze patient-derived material to identify onco-relevant mutations including single-nucleotide variants, insertions-deletions, copy number variants and translocations. We’ll also focus on how known reference standards have been shown to be vital in ensuring data generated from NGS assays is accurate and reproducible.
Molecular QC: Using Reference Standards in NGS Pipelines
Molecular QC: Using Reference Standards in NGS Pipelines
Candy Smellie
DNA sequence analysis and genotyping of biological samples using innovative instrumentation, such as next-generation sequencing (NGS) platforms, is often limited by the small amount of sample available. The REPLI-g Single Cell Kit is specially designed to uniformly amplify genomic DNA from single cells (1 to <1000 bacterial or tumor cells) or purified genomic DNA with complete genome coverage. Additional protocols are also available for use with fresh or dried blood or fresh or frozen tissue. Dedicated buffers and reagents undergo a unique, controlled decontamination procedure to avoid amplification of contaminating DNA, ensuring highly reliable results every time. Accurate amplification of genomes with negligible sequence bias and no genomic drop-outs is achieved with innovative Multiple Displacement Amplification (MDA) technology. In contrast to PCR-based WGA technologies, high fidelity rates are increased up to 1000-fold, avoiding costly false positive or negative results.
Whole Genome Amplification from Single Cell
Whole Genome Amplification from Single Cell
QIAGEN
Genome in a Bottle: Towards new benchmarks for the “dark matter” of the human genome
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
GenomeInABottle
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GenomeInABottle
GIAB for AMP GeT-RM Forum - How well can you detect difficult variants? Benchmarking with Genome in a Bottle
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM Forum
GenomeInABottle
Tools for Using NIST Reference Materials
Tools for Using NIST Reference Materials
Tools for Using NIST Reference Materials
GenomeInABottle
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
GenomeInABottle
What is the impact of assay failure in your laboratory and how do you monitor for it? The most heavily degraded samples are not suitable for standard exome coverage: sometimes it’s not even a matter of getting bad sequencing, you might get nothing at all! FFPE artifacts increase with storage time Artifacts go against the statistical power of your variant calling analysis Molecular reference standards help filter out bad mappings and spurious variants Bioinformatics pipelines allow adding Molecular Reference Standards in your joint variant calling pipeline Genome In A Bottle Reference Standards are invaluable for validating variant calling analysis NIST and its collaborators shared datasets created with most NGS technologies Horizon Diagnostics shared annotated, merged variant calls from NIST for the Ashkenazim Trio ~35K variants are predicted having high or moderate impact within the Trio GM24385 (Ashkenazim Son) includes 352 small variants with high/moderate impact which are absent in Father and Mother Routinely monitor the performance of your workflows and assays with independent external controls
Molecular QC: Interpreting your Bioinformatics Pipeline
Molecular QC: Interpreting your Bioinformatics Pipeline
Candy Smellie
GIAB Technical Germline Benchmark roadmap discussion
GIAB Technical Germline Benchmark roadmap discussion
GIAB Technical Germline Benchmark roadmap discussion
GenomeInABottle
Aug2013 illumina platinum genomes
Aug2013 illumina platinum genomes
GenomeInABottle
Next generation sequencing has revolutionized clinical testing but has also created novel challenges. This presentation will give an overview of state of the art clinical NGS and discuss validation, clinical implementation as well as the migration from gene panels to exome sequencing for inherited disorders with clinical and genetic heterogeneity. In addition, important shortcomings such as difficulties with regions of high sequence homology will be discussed.
NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1
QIAGEN
This slidedeck details two comprehensive informatics solutions — the Biomedical Genomics Workbench and Ingenuity Knowledge Base Variant Analysis platforms. We show the intuitive user interface of CLC Cancer Research Workbench and demonstrate how the rich biological content from Ingenuity Knowledge Base helps you rapidly identify critical variants in your samples.
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
QIAGEN
Aug2013 NIST highly confident genotype calls for NA12878
Aug2013 NIST highly confident genotype calls for NA12878
GenomeInABottle
Pancreatic cancer is a uniquely lethal malignancy characterized by frequent mutations in KRAS, CDKN2A, SMAD4, TP53 and many others. We have shown that KRAS mutation can be detected in cell-free, circulating tumor DNA (ctDNA) isolated from the plasma in a subset of patients and is associated with poor prognosis. The ability to simultaneously detect multiple pancreatic cancer-specific mutations in ctDNA would open a new avenue for detection of clinically-relevant mutations. In this study, we performed ultra-deep sequencing of ctDNA from advanced pancreatic cancer patients prior to treatment with Gemcitabine and Erlotinib following target enrichment. Somatic, non-synonymous variants were identified in 29 different genes at allele frequencies typically less than 0.5%. Updated results of ultra-deep NGS analysis will be presented.
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
QIAGEN
GIAB ASHG 2019 Structural Variant poster
GIAB ASHG 2019 Structural Variant poster
GIAB ASHG 2019 Structural Variant poster
GenomeInABottle
GIAB and long reads for bio it world 190417
GIAB and long reads for bio it world 190417
GIAB and long reads for bio it world 190417
GenomeInABottle
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GenomeInABottle
Identification and monitoring of cancer mutations from cell free DNA-Seq data is a key application in liquid biopsy. In this part of the webinar we will show how mutations can be best identified from this type of data and how they can be interpreted. Furthermore, potential challenges when analyzing this type of data will be discussed together with relevant strategies.
Analysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNA
QIAGEN
ABRF update
Aug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plans
GenomeInABottle
What's hot
(20)
140127 abrf interlaboratory study proposal
140127 abrf interlaboratory study proposal
Molecular QC: Using Reference Standards in NGS Pipelines
Molecular QC: Using Reference Standards in NGS Pipelines
Whole Genome Amplification from Single Cell
Whole Genome Amplification from Single Cell
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
Genome in a Bottle - Towards new benchmarks for the “dark matter” of the huma...
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB GRC Workshop ASHG 2019 Billy Rowell Evaluation of v4 with CCS GATK
GIAB for AMP GeT-RM Forum
GIAB for AMP GeT-RM Forum
Tools for Using NIST Reference Materials
Tools for Using NIST Reference Materials
GIAB update for GRC GIAB workshop 191015
GIAB update for GRC GIAB workshop 191015
Molecular QC: Interpreting your Bioinformatics Pipeline
Molecular QC: Interpreting your Bioinformatics Pipeline
GIAB Technical Germline Benchmark roadmap discussion
GIAB Technical Germline Benchmark roadmap discussion
Aug2013 illumina platinum genomes
Aug2013 illumina platinum genomes
NGS in Clinical Research: Meet the NGS Experts Series Part 1
NGS in Clinical Research: Meet the NGS Experts Series Part 1
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Advanced NGS Data Analysis & Interpretation- BGW + IVA: NGS Tech Overview Web...
Aug2013 NIST highly confident genotype calls for NA12878
Aug2013 NIST highly confident genotype calls for NA12878
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
Utilization of NGS to Identify Clinically-Relevant Mutations in cfDNA: Meet t...
GIAB ASHG 2019 Structural Variant poster
GIAB ASHG 2019 Structural Variant poster
GIAB and long reads for bio it world 190417
GIAB and long reads for bio it world 190417
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
GRC GIAB Workshop ASHG 2019 Small Variant Benchmark
Analysis and Interpretation of Cell-free DNA
Analysis and Interpretation of Cell-free DNA
Aug2014 abrf interlaboratory study plans
Aug2014 abrf interlaboratory study plans
Similar to Giab sv genotyping
Presentation by Fritz Sedlazeck at GRC/GIAB ASHG 2017 workshop "Getting the most from the reference assembly and reference materials" on characterizing human structural variation.
Ashg sedlazeck grc_share
Ashg sedlazeck grc_share
Genome Reference Consortium
Tute Genomics is cloud-based software that can rapidly analyze entire human genomes. The cost of whole genome sequencing is dropping rapidly and we are in the middle of a genomic revolution. Tute is opening a new door for personalized medicine by helping researchers & healthcare organizations analyze human genomes.
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Towards Precision Medicine: Tute Genomics, a cloud-based application for anal...
Reid Robison
GTC SCT60103 Group 5 Assignment
Next Generation Sequencing
Next Generation Sequencing
JoshuaLee309
"Next Generation Sequencing for Identification and Subtyping of Foodborne Pathogens" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by the National Institute for Standards and Technology October 2014 by Rebecca Lindsey, PhD from Enteric Diseases Laboratory Branch of the CDC.
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Nathan Olson
"Next Generation Sequencing for Identification and Subtyping of Foodborne Pathogens" presentation at the Standards for Pathogen Identification via NGS (SPIN) workshop hosted by National Institute for Standards and Technology October 2014 by Rebecca Lindsey, PhD from Enteric Diseases Laboratory Branch of the CDC.
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
Next Generation Sequencing for Identification and Subtyping of Foodborne Pat...
nist-spin
SANGER SEQUENCING - 1st generation sequencing Sanger Sequencing Workflow: PCR amplification (target enrichment) PCR purification (primer, dNTPs) Sequencing reaction (bi-directional) Sequencing purification (primer, dNTPs, ddNTPs) Electrophoretic run on sequencer Sequencing lecture Alignment to reference SANGER SEQUENCING: LIMITATIONS Analytical sensitivity*: 99% PCR-Based no detection deletion/duplication rearrangements del/dup BRCA = 4-28% of all BRCA mutations in most population** Level of mosaicism > 20% Low throughput (82496 capillary tubes) Labor intensive Time consuming High cost (large size gene or more genes)
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA